List of works - Chiara De Divitiis

A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report.

scientific article

Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors.

scientific article published on October 2016

Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?

scientific article

CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients

scientific article published on 29 November 2016

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

scientific article published on 6 January 2016

Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases

scientific article published on 27 June 2015

Everolimus and pancreatic neuroendocrine tumors (PNETs): Activity, resistance and how to overcome it.

scientific article published on 27 June 2015

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.

scientific article published on 3 May 2018

Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice ⬇️

scientific article published on 13 August 2019

Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples

article

Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials

scientific article

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors

scientific article published on 16 October 2018

Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment

scientific article published on 01 May 2019

Metastatic colorectal cancer: role of target therapies and future perspectives

scientific article published on 8 February 2017

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

scientific article published on 13 April 2018

Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study

scientific article published on 01 March 2020

Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.

scientific article published in April 2017

Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor

scientific article published on 01 January 2020

Obesity and cancer: biological links and treatment implications

scientific article published on 30 March 2017

Prognostic and predictive response factors in colorectal cancer patients: between hope and reality

scientific article

Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy

scientific article published on 27 January 2016

Serum and tissue markers in colorectal cancer: State of art.

scientific article published on 27 January 2017

Therapeutic sequences in patients with grade 1-2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group

scientific article published on 14 March 2019

Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey.

scientific article

[Late complete response after long remission from treatment with FOLFIRI-aflibercept for metastatic colorectal cancer after progression to FOLFOX-bevacizumab].

scientific article published in August 2015

List of works by Chiara De Divitiis

A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report.

Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors.

Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?

CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases

Everolimus and pancreatic neuroendocrine tumors (PNETs): Activity, resistance and how to overcome it.

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.

Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice ⬇️

Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples

Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors

Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment

Metastatic colorectal cancer: role of target therapies and future perspectives

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study

Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.

Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor

Obesity and cancer: biological links and treatment implications

Prognostic and predictive response factors in colorectal cancer patients: between hope and reality

Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy

Serum and tissue markers in colorectal cancer: State of art.

Therapeutic sequences in patients with grade 1-2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group

Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey.

[Late complete response after long remission from treatment with FOLFIRI-aflibercept for metastatic colorectal cancer after progression to FOLFOX-bevacizumab].